Mitochondria–Lysosome Quality Flux in Aging Mesenchymal Stem/Stromal Cells: Quality-Control Bottlenecks and Therapeutic Opportunities for Regenerative Decline
Open Access
Abstract
Aging mesenchymal stem/stromal cells (MSCs) lose regenerative capacity as redox imbalance, mitochondrial damage, defective organelle quality control and chronic inflammation converge. Yet these processes are commonly considered in isolation, obscuring whether damaged mitochondrial cargo reaches lysosomes and is ultimately degraded. Here, we define mitochondria–lysosome quality flux (MLQF) as an author-proposed, evidence-graded framework that tracks mitochondrial damage from recognition and sorting through lysosomal delivery to terminal lysosomal degradation in aging MSCs. The framework explicitly separates delivery to an acidic compartment from completed degradation and distinguishes direct MSC evidence from cross-model mechanisms and candidate pathways. MSC studies most strongly support macroautophagy-dependent mitophagy, particularly when assessed using dynamic flux reporters. By contrast, mitochondria-derived vesicles and microautophagy-like or piecemeal routes remain incompletely validated in MSCs. Studies in non-MSC systems further show that mitochondria–lysosome contact sites can support lysosomal acidification, although their contribution to natural MSC aging remains unresolved. By locating rate-limiting defects across this continuum, MLQF provides a testable basis for linking incomplete mitochondrial clearance to inflammatory signaling, lineage drift and regenerative decline, and for selecting bottleneck-matched interventions.Keywords
Funding Information
- Science and Technology Research Project of the Jiangxi Provincial Department of Education (GJJ2401828)
This publication has 149 references indexed in Scilit:
- Mitochondria‐Localized Nestin Protects Mesenchymal Stem Cells from Senescence by Maintaining Cristae Structure and FunctionAdvanced Science, 2025
- An emerging role of mitochondrial quality control in bone metabolism: from molecular mechanisms to targeted therapeutic interventionsCellular and Molecular Life Sciences, 2025
- WAC Facilitates Mitophagy‐mediated MSC Osteogenesis and New Bone Formation via Protecting PINK1 from Ubiquitination‐Dependent DegradationAdvanced Science, 2024
- ATG and ESCRT control multiple modes of microautophagyFEBS Letters, 2023
- Bone-targeted delivery of senolytics to eliminate senescent cells increases bone formation in senile osteoporosisActa Biomaterialia, 2022
- Impairment of APPL1/Myoferlin facilitates adipogenic differentiation of mesenchymal stem cells by blocking autophagy flux in osteoporosisCellular and Molecular Life Sciences, 2022
- Apoptotic vesicles rejuvenate mesenchymal stem cells via Rab7-mediated autolysosome formation and alleviate bone loss in aging miceNano Research, 2022
- Age‐related changes in the energy of human mesenchymal stem cellsJournal of Cellular Physiology, 2021
- Exosomes from antler stem cells alleviate mesenchymal stem cell senescence and osteoarthritisProtein & Cell, 2021
- Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality controlThe EMBO Journal, 2014